 |
 |

A Practical Technique for Differentiation of Subepidermal Bullous Diseases
Localization of In VivoBound IgG by Laser Scanning Confocal Microscopy
Katarzyna Wo niak, MD;
Takashi Kazama, MD;
Cezary Kowalewski, MD
Arch Dermatol. 2003;139:1007-1011.
Objective To develop a practical technique to distinguish autoimmune subepidermal bullous diseases.
Design A prospective study.
Setting Academic referral centerthe Department of Dermatology, Medical University of Warsaw.
Patients Forty-two patients fulfilling clinical, immunological, and/or immunoelectron microscopic criteria for bullous pemphigoid (n = 31), mucous membrane pemphigoid (n = 6), or epidermolysis bullosa acquisita (n = 5), diagnosed as having disease and treated from January 1, 1997, to December 31, 2002.
Main Outcome Measures We applied laser scanning confocal microscopy to determine the localization of in vivobound IgG at the basement membrane zone in biopsy specimens taken from patients' skin to compare the localization of basement membrane zone markers: antibody against 4 integrin, antibody against laminin 5, and antibody against type IV collagen. In vivobound IgG was visualized by labeling with fluorescein isothiocyanateconjugated antihuman IgG antibody, whereas basement membrane zone markers were labeled with antimouse Cy5-conjugated antibodies.
Results In patients with bullous pemphigoid, in vivobound IgG was localized on the epidermal side of laminin 5 and co-localized with 4 integrin. In patients with mucous membrane pemphigoid, IgG was in vivo bound to the dermal-epidermal junction between localization of laminin 5 and type IV collagen. In patients with epidermolysis bullosa acquisita, in vivobound IgG was present on the dermal side of type IV collagen.
Conclusions Laser scanning confocal microscopy allows precise localization of in vivobound IgG in patients' skin and, thus, it is a rapid method for the differentiation of mucous membrane pemphigoid from bullous pemphigoid and epidermolysis bullosa acquisita. This tool is suitable for the routine diagnosis of individual patients and for retrospective studies. This method is of special value in those patients in whom circulating autoantibodies are not detectable.
From the Departments of Dermatology, Medical University of Warsaw, Warsaw, Poland (Drs Wo niak and Kowalewski), and Niigata University School of Medicine, Niigata, Japan (Dr Kazama). The authors have no relevant financial interest in this article.
|